Cohance Lifesciences Limited
Cohance Lifesciences Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: COHANCE and BSE: 543064 (ISIN INE03QK01018).
It has a market capitalisation of ₹17,512 crore, a last close of ₹457.70 on 2026-10-19, a one-year return of -48.6%.
Valuation: a price-to-earnings ratio of 165x, a price-to-book ratio of 4.48x, a dividend yield of 0.0%.
Profitability: return on equity of 6.4%, return on capital employed of 6.3%, an operating margin of 14.8%.
Growth: sales growth of 19.2% a year over three years, net profit growth of -24.2% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.04x, promoter holding of 57.5%.
| Metric | Value |
|---|---|
| Market capitalisation | 17,512 |
| Last close | ₹457.70 |
| P/E (TTM) | 165x |
| P/B | 4.48x |
| Dividend yield | 0.0% |
| ROE (FY) | 6.4% |
| ROCE (FY) | 6.3% |
| Operating margin (TTM) | 14.8% |
| Sales growth, 3-year CAGR | 19.2% |
| Profit growth, 3-year CAGR | -24.2% |
| Debt / equity | 0.04x |
| Promoter holding | 57.5% |
| 1-year return | -48.6% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means